Akèy › Sarkom tisi mou › Texas › Dallas

Etid klinik pou Sarkom tisi mou nan Dallas, TX

6 etid pou Sarkom tisi mou ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

DESTINY-PANTUMOUR04

Ap rekriteEtid obsèvasyon

Research Site, Dallas

Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Ap rekriteFaz 1/2

The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas

Jiska laj 25 · Tout sèks · Mizajou Sep 25, 2026 · NCT04094610

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)

Ap rekriteFaz 1

Ut Southwestern Medical Center, Dallas

Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07139990

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2

UT Southwestern Medical Center, Dallas

Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Ap rekriteFaz 1/2

Children's Health Dallas, Dallas

Laj 2 a 30 · Tout sèks · Mizajou Feb 3, 2026 · NCT05734066

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2

Mary Crowley Cancer Research, Dallas

Laj 18 ak plis · Tout sèks · Mizajou Oct 8, 2025 · NCT04370587

Etid Sarkom tisi mou nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.